322 related articles for article (PubMed ID: 34153968)
1. Disparities between Asian and Non-Asian Thrombolyzed Acute Ischemic Stroke Patients in the Enhanced Control of Hypertension and Thrombolysis Stroke Trial.
Chen C; Wang X; Chen X; Ouyang M; Sun L; Arima H; Robinson T; Lindley RI; Chalmers J; Li G; Song L; Anderson CS;
Cerebrovasc Dis; 2021; 50(5):560-566. PubMed ID: 34153968
[TBL] [Abstract][Full Text] [Related]
2. Interaction of Blood Pressure Lowering and Alteplase Dose in Acute Ischemic Stroke: Results of the Enhanced Control of Hypertension and Thrombolysis Stroke Study.
Wang X; Song L; Yang J; Sun L; Moullaali TJ; Sandset EC; Delcourt C; Lindley RI; Robinson TG; Minhas JS; Arima H; Chalmers J; Kim JS; Sharma V; Wang JG; Pontes-Neto O; Lavados PM; Olavarría VV; Lee TH; Levi C; Martins SO; Thang NH; Anderson CS;
Cerebrovasc Dis; 2019; 48(3-6):207-216. PubMed ID: 31812956
[TBL] [Abstract][Full Text] [Related]
3. Associations of Early Systolic Blood Pressure Control and Outcome After Thrombolysis-Eligible Acute Ischemic Stroke: Results From the ENCHANTED Study.
Wang X; Minhas JS; Moullaali TJ; Di Tanna GL; Lindley RI; Chen X; Arima H; Chen G; Delcourt C; Bath PM; Broderick JP; Demchuk AM; Donnan GA; Durham AC; Lavados PM; Lee TH; Levi C; Martins SO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Silva F; Thang NH; Wang JG; Woodward M; Chalmers J; Song L; Anderson CS; Robinson TG;
Stroke; 2022 Mar; 53(3):779-787. PubMed ID: 34702064
[TBL] [Abstract][Full Text] [Related]
4. Characteristics, management and response to alteplase in China versus non-China participants of the ENCHANTED trial.
Song L; Wang X; Robinson T; Lindley RI; Arima H; Lavados PM; Chen X; Chalmers J; Anderson CS
Stroke Vasc Neurol; 2017 Jun; 2(2):53-58. PubMed ID: 28959492
[TBL] [Abstract][Full Text] [Related]
5. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.
Anderson CS; Huang Y; Lindley RI; Chen X; Arima H; Chen G; Li Q; Billot L; Delcourt C; Bath PM; Broderick JP; Demchuk AM; Donnan GA; Durham AC; Lavados PM; Lee TH; Levi C; Martins SO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Silva F; Song L; Thang NH; Wardlaw JM; Wang JG; Wang X; Woodward M; Chalmers J; Robinson TG;
Lancet; 2019 Mar; 393(10174):877-888. PubMed ID: 30739745
[TBL] [Abstract][Full Text] [Related]
6. Early decompressive hemicraniectomy in thrombolyzed acute ischemic stroke patients from the international ENCHANTED trial.
Xia C; Wang X; Lindley RI; Delcourt C; Chen X; Zhou Z; Guo R; Carcel C; Malavera A; Calic Z; Mair G; Wardlaw JM; Robinson TG; Anderson CS
Sci Rep; 2021 Aug; 11(1):16495. PubMed ID: 34389772
[TBL] [Abstract][Full Text] [Related]
7. Lipid-Lowering Pretreatment and Outcome Following Intravenous Thrombolysis for Acute Ischaemic Stroke: A Post Hoc Analysis of the Enhanced Control of Hypertension and Thrombolysis Stroke Study Trial.
Minhas JS; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Donnan GA; Kim JS; Lavados PM; Lee TH; Martins SCO; Olavarría VV; Pandian JD; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Thang NH; Wang JG; Woodward M; Chalmers J; Anderson CS; Robinson TG;
Cerebrovasc Dis; 2018; 45(5-6):213-220. PubMed ID: 29705803
[TBL] [Abstract][Full Text] [Related]
8. Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study).
Robinson TG; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Demchuk AM; Donnan GA; Kim JS; Lavados PM; Lee TH; Lindley RI; Martins SCO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Nguyen TH; Wang JG; Woodward M; Chalmers J; Anderson CS;
Stroke; 2017 Jul; 48(7):1877-1883. PubMed ID: 28619989
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of intensive-blood pressure versus standard-blood pressure-lowering treatment in patients with severe ischemic stroke in the ENCHANTED trial.
Minhas JS; Wang X; Lindley RI; Delcourt C; Song L; Woodward M; Lee TH; Broderick JP; Pontes-Neto OM; Kim JS; Ricci S; Lavados PM; Bath PM; Durham AC; Wang JG; Sharma VK; Demchuk AM; Martins SO; Chalmers J; Anderson CS; Robinson TG;
J Hypertens; 2021 Feb; 39(2):280-285. PubMed ID: 33031175
[TBL] [Abstract][Full Text] [Related]
10. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.
Huang Y; Sharma VK; Robinson T; Lindley RI; Chen X; Kim JS; Lavados P; Olavarría V; Arima H; Fuentes S; Nguyen HT; Lee TH; Parsons MW; Levi C; Demchuk AM; Bath PM; Broderick JP; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Pandian J; Ricci S; Stapf C; Woodward M; Wang J; Chalmers J; Anderson CS;
Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995
[TBL] [Abstract][Full Text] [Related]
11. Ethnicity and Other Determinants of Quality of Functional Outcome in Acute Ischemic Stroke: The ENCHANTED Trial.
Chen X; Wang X; Delcourt C; Li J; Arima H; Hackett ML; Robinson T; Lavados PM; Lindley RI; Chalmers J; Anderson CS;
Stroke; 2020 Feb; 51(2):588-593. PubMed ID: 31822251
[TBL] [Abstract][Full Text] [Related]
12. Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke: Secondary Analysis of the ENCHANTED Randomized Clinical Trial.
Wang X; Robinson TG; Lee TH; Li Q; Arima H; Bath PM; Billot L; Broderick J; Demchuk AM; Donnan G; Kim JS; Lavados P; Lindley RI; Martins SO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sharma VK; Thang NH; Wang JG; Woodward M; Anderson CS; Chalmers J;
JAMA Neurol; 2017 Nov; 74(11):1328-1335. PubMed ID: 28973174
[TBL] [Abstract][Full Text] [Related]
13. Brain Imaging Signs and Health-Related Quality of Life after Acute Ischemic Stroke: Analysis of ENCHANTED Alteplase Dose Arm.
Chen X; Delcourt C; Sun L; Zhou Z; Yoshimura S; You S; Malavera A; Torii-Yoshimura T; Carcel C; Arima H; Hackett ML; Robinson T; Song L; Wang X; Lindley RI; Chalmers J; Anderson CS;
Cerebrovasc Dis; 2020; 49(4):427-436. PubMed ID: 32702699
[TBL] [Abstract][Full Text] [Related]
14. Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke.
Anderson CS; Robinson T; Lindley RI; Arima H; Lavados PM; Lee TH; Broderick JP; Chen X; Chen G; Sharma VK; Kim JS; Thang NH; Cao Y; Parsons MW; Levi C; Huang Y; Olavarría VV; Demchuk AM; Bath PM; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Ricci S; Roffe C; Pandian J; Billot L; Woodward M; Li Q; Wang X; Wang J; Chalmers J;
N Engl J Med; 2016 Jun; 374(24):2313-23. PubMed ID: 27161018
[TBL] [Abstract][Full Text] [Related]
15. Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review.
Wang X; You S; Sato S; Yang J; Carcel C; Zheng D; Yoshimura S; Anderson CS; Sandset EC; Robinson T; Chalmers J; Sharma VK
Stroke Vasc Neurol; 2018 Mar; 3(1):28-33. PubMed ID: 29600005
[TBL] [Abstract][Full Text] [Related]
16. Who may benefit from lower dosages of intravenous tissue plasminogen activator? Results from a cluster data analysis.
Dong Y; Han Y; Shen H; Wang Y; Ma F; Li H; Wang Y; Dong Q
Stroke Vasc Neurol; 2020 Dec; 5(4):348-352. PubMed ID: 32611728
[TBL] [Abstract][Full Text] [Related]
17. Thrombolysis outcomes according to arterial characteristics of acute ischemic stroke by alteplase dose and blood pressure target.
Zhou Z; Xia C; Mair G; Delcourt C; Yoshimura S; Liu X; Chen Z; Malavera A; Carcel C; Chen X; Wang X; Al-Shahi Salman R; Robinson TG; Lindley RI; Chalmers J; Wardlaw JM; Parsons MW; Demchuk AM; Anderson CS
Int J Stroke; 2022 Jun; 17(5):566-575. PubMed ID: 34096413
[TBL] [Abstract][Full Text] [Related]
18. The Risk of Hemorrhagic Transformation After Thrombolysis for Acute Ischemic Stroke in Chinese Versus North Americans: A Comparative Study.
Xu X; Wang D; Wang F; Norton C; Liu X; Selim M
J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2381-2387. PubMed ID: 29778315
[TBL] [Abstract][Full Text] [Related]
19. Low-Dose vs Standard-Dose Alteplase in Acute Lacunar Ischemic Stroke: The ENCHANTED Trial.
Zhou Z; Delcourt C; Xia C; Yoshimura S; Carcel C; Torii-Yoshimura T; You S; Malavera A; Chen X; Hackett ML; Woodward M; Chalmers J; Xu J; Robinson TG; Parsons MW; Demchuk AM; Lindley RI; Mair G; Wardlaw JM; Anderson CS
Neurology; 2021 Mar; 96(11):e1512-e1526. PubMed ID: 33536271
[TBL] [Abstract][Full Text] [Related]
20. Dual thrombolytic therapy with mutant pro-urokinase and small bolus alteplase for ischemic stroke (DUMAS): study protocol for a multicenter randomized controlled phase II trial.
van der Ende NAM; Roozenbeek B; Smagge LEM; Luijten SPR; Aerden LAM; Kraayeveld P; van den Wijngaard IR; Lycklama À Nijeholt GJ; den Hertog HM; Flach HZ; Wallace AC; Gurewich V; Del Zoppo GJ; Meurer WJ; Lingsma HF; van der Lugt A; Dippel DWJ;
Trials; 2022 Aug; 23(1):641. PubMed ID: 35945566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]